Privium Fund Management B.V.

SEC CIK: 0001795097
Latest filing: Aug 7, 2026

SEC filings (opens in a new tab)

RPRX holding history

Royalty Pharma plc in every 13F filed by Privium Fund Management B.V., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RPRX overview All 13F holders of RPRX Full Q2 2026 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2021

Holdings of RPRX by Privium Fund Management B.V., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−243,322−100.0%	Sold out	Holders
Q1 2022	243,322	$9.48M	2.1%	+333+0.1%	Added	Holders
Q4 2021	242,989	$9.74M	1.9%	–	No prior filing	Holders